Discussion of ABC7 Consensus and German Recommendations.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS

ACS Applied Bio Materials Pub Date : 2024-05-29 eCollection Date: 2024-05-01 DOI:10.1055/a-2263-5152

Michael Untch, Nina Ditsch, Peter A Fasching, Steffi Busch, Johannes Ettl, Renate Haidinger, Nadia Harbeck, Christian Jackisch, Diana Lüftner, Lothar Müller, Eugen Ruckhäberle, Eva Schumacher-Wulf, Christoph Thomssen, Rachel Wuerstlein, Volkmar Müller

{"title":"Discussion of ABC7 Consensus and German Recommendations.","authors":"Michael Untch, Nina Ditsch, Peter A Fasching, Steffi Busch, Johannes Ettl, Renate Haidinger, Nadia Harbeck, Christian Jackisch, Diana Lüftner, Lothar Müller, Eugen Ruckhäberle, Eva Schumacher-Wulf, Christoph Thomssen, Rachel Wuerstlein, Volkmar Müller","doi":"10.1055/a-2263-5152","DOIUrl":null,"url":null,"abstract":"<p><p>The rationale behind the \"International Consensus Conference for Advanced Breast Cancer\" (ABC) is to standardize the treatment of patients with advanced or metastatic breast cancer worldwide using an evidence-based approach. The aim is also to ensure that patients in all countries receive adequate treatment based on current treatment recommendations and standards. The 7th International Consensus Conference on Advanced Breast Cancer (ABC7) took place from November 9 to 12, 2023 in Lisbon/Portugal. ABC7 focused on metastatic disease as well as on locally advanced and inflammatory breast cancer. Special topics included the treatment of oligometastatic patients, leptomeningeal disease, treatment of brain metastases, and pregnant women with ABC. As in previous years, patient advocates from all over the world participated in the consensus conference and were involved in decision making.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":"84 5","pages":"431-442"},"PeriodicalIF":4.6000,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11136526/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2263-5152","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}

引用次数: 0

Abstract

The rationale behind the "International Consensus Conference for Advanced Breast Cancer" (ABC) is to standardize the treatment of patients with advanced or metastatic breast cancer worldwide using an evidence-based approach. The aim is also to ensure that patients in all countries receive adequate treatment based on current treatment recommendations and standards. The 7th International Consensus Conference on Advanced Breast Cancer (ABC7) took place from November 9 to 12, 2023 in Lisbon/Portugal. ABC7 focused on metastatic disease as well as on locally advanced and inflammatory breast cancer. Special topics included the treatment of oligometastatic patients, leptomeningeal disease, treatment of brain metastases, and pregnant women with ABC. As in previous years, patient advocates from all over the world participated in the consensus conference and were involved in decision making.

查看原文本刊更多论文

讨论 ABC7 共识和德国建议。

晚期乳腺癌国际共识会议"（ABC）的宗旨是在全球范围内采用循证方法对晚期或转移性乳腺癌患者进行标准化治疗。其目的还在于确保所有国家的患者都能根据当前的治疗建议和标准接受适当的治疗。第七届晚期乳腺癌国际共识会议（ABC7）于 2023 年 11 月 9 日至 12 日在葡萄牙里斯本举行。ABC7重点关注转移性疾病以及局部晚期和炎症性乳腺癌。特别议题包括少转移患者的治疗、脑外膜疾病、脑转移的治疗以及患有乳腺癌的孕妇。与往年一样，来自世界各地的病人权益倡导者参加了共识会议，并参与了决策。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ACS Applied Bio Materials Chemistry-Chemistry (all)

CiteScore

9.40

自引率

2.10%

发文量

464